| Literature DB >> 28736550 |
Thorben Grau1, Andreas Vilcinskas1,2, Gerrit Joop1.
Abstract
Enterococcus mundtii strains isolated from the larval feces of the Mediterranean flour moth Ephestia kuehniella show antimicrobial activity against a broad spectrum of Gram-positive and Gram-negative bacteria. The in vitro probiotic characterization of one isolate revealed a high auto-aggregation score, a hydrophilic cell surface, tolerance for low pH, no hemolytic activity, and susceptibility to all tested antibiotics. We used the red flour beetle Tribolium castaneum, an established model organism, for the in vivo characterization of one probiotic E. mundtii isolate from E. kuehniella larvae. Tribolium castaneum larvae were fed orally with the probiotic isolate or the corresponding supernatant and then infected with either the entomopathogen Bacillus thuringiensis or Pseudomonas entomophila. Larvae exposed to the isolate or the supernatant showed increased survival following infection with B. thuringiensis but not P. entomophila. Heat treatment or treatment with proteinase K reduced the probiotic effect of the supernatant. However, the increased resistance attracts a fitness penalty manifested as a shorter lifespan and reduced fertility. T. castaneum has, pending on further research, the potential as an alternative model for the pre-screening of probiotics.Entities:
Keywords: Bacillus thuringiensis; Enterococcus mundtii; Tribolium castaneum; antimicrobial; in vivo model; probiotics
Year: 2017 PMID: 28736550 PMCID: PMC5500611 DOI: 10.3389/fmicb.2017.01261
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Agar spot on lawn test with E. mundtii isolates against indicator bacteria.
| Isolated | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator strains | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| + | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| + | + | + | + | + | ++ | + | + | + | + | + | + | + | + | + | |
| + | ++ | ++ | ++ | ++ | + | + | + | + | + | + | + | ++ | + | ++ | |
| + | + | + | - | + | + | - | - | + | + | - | - | - | + | + | |
| + | + | + | - | - | + | - | - | - | + | - | - | + | + | + | |
| + | - | - | + | + | - | - | - | + | - | - | + | + | + | ||
| + | ++ | ++ | ++ | ++ | + | ++ | ++ | + | ++ | ++ | ++ | ++ | ++ | ++ | |
| + | + | - | + | - | - | + | - | - | ++ | - | + | - | + | + | |
| + | ++ | ++ | + | + | + | + | + | + | + | + | + | ++ | + | ++ | |
| + | - | + | + | + | + | - | - | - | + | - | - | + | + | + | |
| + | + | - | - | - | - | - | - | - | - | - | - | - | + | + | |
Agar well-diffusion assay with CFS from E. mundtii isolate 1 with different treatments against indicator bacteria.
| Indicator strains | Crude | 100 × fold | Proteinase K | Catalase | Heated |
|---|---|---|---|---|---|
| 0 | 4.75 ± 0.32 | 4.23 ± 0.09 | 4.29 ± 0.12 | 4.58 ± 0.58 | |
| 0 | 4.75 ± 0.43 | 4.81 ± 0.69 | 4.33 ± 0.27 | 4.60 ± 0.57 | |
| 0 | 6.3 ± 0.17 | 6.12 ± 0.08 | 4.73 ± 1.00 | 6.14 ± 0.26 | |
| 0 | 2.25 ± 0.53 | 1.02 ± 0.15 | 2.43 ± 0.29 | 2.55 ± 0.06 | |
| 0 | 3.27 ± 0.37 | 0.56 ± 0.96 | 2.82 ± 0.13 | 2.97 ± 0.34 | |
| 0 | 2.03 ± 1.19 | 0.97 ± 0.86 | 2.71 ± 0.37 | 2.08 ± 1.05 | |
| 0 | 3.92 ± 0.41 | 3.68 ± 0.69 | 3.83 ± 0.46 | 3.69 ± 0.26 | |
| 0 | 4.9 ± 0.22 | 4.49 ± 0.57 | 4.07 ± 0.62 | 4.88 ± 0.39 | |
| 0 | 3.83 ± 0.42 | 3.68 ± 0.36 | 3.62 ± 0.31 | 3.52 ± 0.38 | |
| 0 | 6.72 ± 0.42 | 6.39 ± 0.31 | 6.33 ± 0.49 | 6.48 ± 0.08 | |
| 0 | 0 | 0 | 0 | 0 | |
Auto-aggregation rate and hydrophobicity of E. mundtii 1.
| Auto-aggregation (%) 5 h | 12.69 ± 1.28 |
| Auto-aggregation (%) 24 h | 89.66 ± 2.83 |
| Hydrophobicity (%) | 8.30 ± 9.4 |
Effect of low pH on E. mundtii 1.
| CFU start | 8.50 ± 0.07 |
| CFU pH 2 after 3 h | 4.11 ± 0.04 |
| CFU pH 3 after 3 h | 6.49 ± 0.05 |
| CFU pH 4 after 3 h | 8.31 ± 0.037 |
Antimicrobial susceptibility of E. mundtii 1.
| Antimicrobial agent | MIC (μg ml-1) |
|---|---|
| Ampicillin | <0.25 |
| Ciprofloxacin | <0.25 |
| Erythromycin | <0.25 |
| Fosfomycin | 4 |
| Kanamycin | 32 |
| Rifampicin | <0.25 |
| Streptomycin | 64 |
| Tetracycline | <0.25 |
| Vancomycin | <0.25 |